regenHU is an innovative biomedical company located in Switzerland, resulting from the joint venture between Delta Robotics Ltd and the CPA Group Ltd. regenHU acts as a biosystem architect exploiting novel bio-manufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. regenHU benefits from exclusive patented technologies resulting from many years of research within International Universities and partners.
Advancements in medical Science, biology, cell-based therapies, as well as the ever increasing market entry barriers induced by biomedical product regulations and legislations, ask for innovative solutions to create organotypic tissue models that demonstrate optimal biological relevance. It is well known nowadays that these requirements can only be fulfilled if Science is able to mimic natural morphologic environments of cellular components. This breakthrough aspect can only be approached by the exploration of the third dimension: regenHU innovate 3D Tissue Engineering.
OUR 3 INNOVATION STREAMS :
- Drug discovery soutions
- Therapeutic product development
- Innnovating equipments with bioengineering expertise
NEWS RELEASE
regenHU introduces the 3DDiscovery® instrument for those who are willing to transition from 2D to 3D Tissue Engineering.
Access the 3DDiscovery® datasheet
THE POTENTIAL OF TISSUE ENGINEERING
Discover the potential of the Biomedical Industry and its emerging sector of Tissue Engineering.
Access international market survey 1
Access international market survey 2
EVENTS
February 2012 | SLAS 2012, Society for Laboratory Automation & Screening @ San Diego, CA, USA
March 2012 | DECHEMA, 3D Cell Culture @ Technopark Zürich, CH
JOBS
If you believe that you can contribute to the success of our company, please feel free to send your detailed CV.
CHALLENGE US
regenHU Ltd
Zone Industrielle le Vivier 16
CH -1690 Villaz-St-Pierre
T +41(0)26 653 72 20
F +41(0)26 653 72 21
E info@regenhu.com